13F reference period
Q2 2026
Security Snapshot
Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) Institutional Ownership
CUSIP: 62856X300
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
21
Shares (Excl. Options)
736,752
Price
$3.90
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- QCLS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 736,752
- Total 13F value
- $2,873,227
- Portfolio coverage rank
- 0%
- Share change
- +111,247
- Value change
- +$433,611
- Number of holders
- 21
- Shares outstanding
- 11,453,200
- SEC-reported price per share
- $0.85
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- QCLS - Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 62856X300.
- 21 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 17 to 21 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,164,696 to $2,873,227.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 21 institutions filings for Q2 2026.
Security key
62856X300
13F reference period
Q2 2026
13F holders
21
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
QCLS full holder history
Q/C TECHNOLOGIES, INC. SEC filings
Q/C TECHNOLOGIES, INC. company facts
Q/C TECHNOLOGIES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 62856X300:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
QCLS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | 74% | $28,646,744 | 8,475,368 | PharmaCyte Biotech, Inc. | 14 Nov 2025 |
As of 30 Jun 2026, 21 institutional investors reported holding 736,752 shares of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS). This represents 6.4% of the company’s total 11,453,200 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 576 | $491 | +$491 | $0.85 | 1 |
| 2026 Q2 | 736,752 | $2,873,227 | +$433,611 | $3.90 | 21 |
| 2026 Q1 | 627,555 | $2,164,696 | -$634,439 | $3.45 | 17 |
| 2025 Q4 | 752,721 | $3,003,189 | +$2,929,686 | $3.99 | 18 |
| 2025 Q3 | 16,820 | $69,803 | +$69,803 | $4.15 | 11 |